CoChat

Association of amyloid-β CSF/PET discordance and tau load 5 years later

Open access
Reimand, Juhan, Collij, Lyduine, Scheltens, Philip, Bouwman, Femke, Ossenkoppele, Rik, for the Alzheimer's Disease Neuroimaging Initiative · 2020 · Neurology
Cited by 50

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Abstract OBJECTIVE To investigate the association between discordant amyloid-β PET and CSF biomarkers at baseline and the emergence of tau pathology 5 years later. METHODS We included 730 ADNI participants without dementia (282 cognitively normal, 448 mild cognitive impairment) with baseline [ 18 F]Florbetapir PET and CSF Aβ42 available. Amyloid-β CSF/PET status was determined at baseline using established cut-offs. Longitudinal data was available for [ 18 F]florbetapir (Aβ) PET (baseline to 4.3±1.9 years), CSF (p)tau (baseline to 2.0±0.1 years), cognition (baseline to 4.3±2.0 years), and [ 18 F]flortaucipir (tau) PET (measured 5.2±1.2 years after baseline to 1.6±0.7 years later). We used linear mixed modelling to study the association between amyloid-β CSF/PET status and tau pathology measured in CSF or using PET. Additionally, we calculated the proportion of CSF+/PET-participants who during follow-up (i) progressed to amyloid-β CSF+/PET+, and/or (ii) became tau-positive based on [ 18 F]flortaucipir PET. RESULTS Amyloid-β CSF+/PET+ (N=318) participants had elevated CSF (p)tau levels and worse cognitive performance at baseline, while CSF+/PET-(N=80) participants were overall similar to the CSF-/PET-(N=306) group. Five years after baseline, [ 18 F]flortaucipir PET uptake in the CSF+/PET-group (1.20±0.13) did not differ from CSF-/PET-(1.18±0.08, p=0.69), but was substantially lower than CSF+/PET+ (1.48±0.44, p<0.001). Of the CSF+/PET-subjects, 21/64 (33%) progressed to amyloid-β CSF+/PET+, whereas only one (3%, difference p<0.05) became tau-positive based on [ 18 F]flortaucipir PET. CONCLUSIONS Sufficient amyloid-β load detectable by both CSF and PET is required before substantial tau deposition emerges. Compared to participants with abnormal amyloid-β levels on PET and CSF, the CSF+/PET-group has a distinctly better prognosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000010739

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 50

Metadata

Authors
Reimand, J., Collij, L., Scheltens, P., Bouwman, F., Ossenkoppele, R., & Initiative, F. T. A. D. N.
Venue
Neurology
Published
2020-11-10
Volume
95
Issue
19
Pages
e2648-e2657
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3086067769
Cited by
50
References
22
FWCI
5.11
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of amyloid-β CSF/PET discordance and tau load 5 years later. https://app.cochat.ai/papers/10.1212/wnl.0000000000010739
The paper
Reimand, J., Collij, L., Scheltens, P., Bouwman, F., Ossenkoppele, R., & Initiative, F. T. A. D. N. (2020). Association of amyloid-β CSF/PET discordance and tau load 5 years later. Neurology. https://doi.org/10.1212/wnl.0000000000010739

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.